New Research Identifies Preferred Survey Instruments for Measuring Medication Satisfaction

Published Dec 12, 2018

DMSRQ and DMSRQ-SF Are Recommended in Type 2 Diabetes Patients

Lawrenceville, NJ, USA—December 12, 2018—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that the Diabetes Medication System Rating Questionnaire (DMSRQ) and the Diabetes Medication System Rating Questionnaire-Short Form (DMSRQ-SF) are the preferred survey instruments for measuring medication satisfaction in patients with type 2 diabetes (T2D) using oral therapy in clinical trials. The report, “A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes,” was published in the November 2018 issue of Value in Health Using specific inclusion criteria, the authors identified and evaluated 8 survey instruments designed to measure satisfaction with medication in T2D patients treated with oral therapy:
  • Diabetes Medication Satisfaction (DiabMedSat)
  • Diabetes Treatment Satisfaction Questionnaire, status version (DTSQs)
  • Diabetes Medication System Rating Questionnaire (DMSRQ)
  • Diabetes Medication System Rating Questionnaire-Short Form (DMSRQ-SF)
  • Diabetes Tablet Treatment Questionnaire (DTTQ)
  • Perceptions About Medications for Diabetes (PAM-D)
  • Satisfaction with Oral Anti-Diabetic Agent Scale (SOADAS)
  • Diabetes Medication Satisfaction Tool (DMSAT])
Each of the 8 selected instruments was assessed based on several measures: inclusion of patients in instrument development, practicality, breadth and depth of health measures, reliability, validity, and responsiveness. Based on in-depth evaluations, the DMSRQ and DMSRQ-SF met the most review criteria and were recommended for measuring medication satisfaction. The authors note that the DTSQs should also be considered in certain circumstances, and the DTTQ may be of interest in the clinical setting because it may offer the side benefit of improving adherence in patients. “Historically, there has been limited information in the literature regarding the psychometric properties of medication satisfaction instruments used in patients with diabetes,” said author Yu Wang, Department of Clinical and Administrative Pharmacy, University of Georgia, Athens, GA, USA. “Although the standards we employed here are certainly important and a good starting point, more work is needed to clearly define the most important attributes of satisfaction with medication. The lack of widely accepted standards and the potential for overlap between constructs within instruments further complicate finding an ideal satisfaction instrument.”

###

  ABOUT ISPOR ISPOR, the professional society for health economics and outcomes research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field. Web: www.ispor.org | LinkedIn: http://bit.ly/ISPOR-LIn | Twitter: www.twitter.com/ISPORorg (@ISPORorg) | YouTube: www.youtube.com/user/ISPORorg/videos | Facebook: www.facebook.com/ISPORorg | Instagram: www.instagram.com/ISPORorg ABOUT VALUE IN HEALTH Value in Health (ISSN 1098-3015) is an international, indexed journal that publishes original research and health policy articles that advance the field of health economics and outcomes research to help healthcare leaders make evidence-based decisions. The journal’s 2017 impact factor score is 5.494. Value in Health is ranked 3rd among 94 journals in healthcare sciences and services, 3rd among 79 journals in health policy and services, and 6th among 353 journals in economics. Value in Health is a monthly publication that circulates to more than 10,000 readers around the world. Web: www.ispor.org/publications/journals/value-in-health | Twitter: www.twitter.com/ISPORJournals (@ISPORjournals)    

Related Stories

ISPOR’s Real-World Evidence Transparency Initiative: Creating a Road Map That Builds Trust

Oct 5, 2020

ISPOR announced the publication of a plan from the Real-World Evidence Transparency Initiative to encourage routine registration of noninterventional real-world evidence studies used to evaluate treatment effects.

ISPOR Introduces New Competencies Framework for Health Economics and Outcomes Research Professionals

Sep 28, 2020

ISPOR announced the publication of its Health Economics and Outcomes Research Competencies Framework™, an established set of HEOR competencies for professionals in the discipline that was published in the September 2020 issue of Value in Health.

Supplementary Measles Immunization Activities Provide More Equitable Results Than Routine Measles Immunization Programs

Aug 11, 2020

Value in Health announced the publication of new research showing that, across 20 low- and middle-income countries, supplementary measles immunization activities tended to provide more equitable vaccination delivery across socioeconomic groups than routine measles immunization programs.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×